ロード中...
The application of phosphoramidate ProTide technology to acyclovir confers anti-HIV inhibition
Recently it has been reported that phosphorylated acyclovir (ACV) inhibits human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in a cell free system. To deliver phosphorylated ACV inside cells we designed ACV monophosphorylated derivatives using ProTide technology. We found that the L-...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2748767/ https://ncbi.nlm.nih.gov/pubmed/19645484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm9007856 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|